Two Sigma Advisers’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-127,854
| Closed | -$5.13M | – | 2499 |
|
|
2025
Q1 | $5.13M | Sell |
127,854
-63,783
| -33% | -$2.68M | 0.01% | 780 |
|
|
2024
Q4 | $8.78M | Buy |
191,637
+44,241
| +30% | +$1.98M | 0.02% | 528 |
|
|
2024
Q3 | $6.91M | Buy |
147,396
+84,000
| +133% | +$3.83M | 0.02% | 596 |
|
|
2024
Q2 | $2.68M | Buy |
+63,396
| New | +$2.78M | 0.01% | 1032 |
|
|
2023
Q3 | – | Sell |
-188,203
| Closed | -$8.99M | – | 2540 |
|
|
2023
Q2 | $8.99M | Sell |
188,203
-556,370
| -75% | -$26.8M | 0.02% | 530 |
|
|
2023
Q1 | $36.3M | Sell |
744,573
-149,474
| -17% | -$7.61M | 0.09% | 212 |
|
|
2022
Q4 | $47.3M | Buy |
894,047
+154,944
| +21% | +$7.64M | 0.13% | 164 |
|
|
2022
Q3 | $32.4M | Buy |
739,103
+316,681
| +75% | +$15.6M | 0.09% | 223 |
|
|
2022
Q2 | $21.1M | Buy |
422,422
+209,736
| +99% | +$10.2M | 0.06% | 313 |
|
|
2022
Q1 | $11.1M | Sell |
212,686
-358,270
| -63% | -$18.5M | 0.03% | 478 |
|
|
2021
Q4 | $33.6M | Buy |
570,956
+128,538
| +29% | +$7.37M | 0.08% | 204 |
|
|
2021
Q3 | $24.2M | Sell |
442,418
-6,917
| -2% | -$385K | 0.06% | 273 |
|
|
2021
Q2 | $23.1M | Sell |
449,335
-152,398
| -25% | -$7.87M | 0.06% | 299 |
|
|
2021
Q1 | $31.1M | Sell |
601,733
-439,464
| -42% | -$24.1M | 0.09% | 253 |
|
|
2020
Q4 | $58.4M | Sell |
1,041,197
-267,618
| -20% | -$14.3M | 0.16% | 141 |
|
|
2020
Q3 | $72.5M | Buy |
1,308,815
+683,000
| +109% | +$35.4M | 0.21% | 111 |
|
|
2020
Q2 | $28.4M | Buy |
625,815
+16,715
| +3% | +$748K | 0.08% | 256 |
|
|
2020
Q1 | $26.9M | Buy |
609,100
+446,973
| +276% | +$17.5M | 0.1% | 232 |
|
|
2019
Q4 | $5.81M | Buy |
162,127
+51,116
| +46% | +$1.9M | 0.01% | 789 |
|
|
2019
Q3 | $3.88M | Sell |
111,011
-191,064
| -63% | -$7.35M | 0.01% | 854 |
|
|
2019
Q2 | $13M | Sell |
302,075
-208,017
| -41% | -$8.62M | 0.03% | 517 |
|
|
2019
Q1 | $22M | Sell |
510,092
-94,872
| -16% | -$3.82M | 0.06% | 388 |
|
|
2018
Q4 | $22.1M | Buy |
604,964
+46,842
| +8% | +$1.74M | 0.06% | 356 |
|
|
2018
Q3 | $22.4M | Buy |
558,122
+4,224
| +0.8% | +$169K | 0.05% | 361 |
|
|
2018
Q2 | $21.2M | Sell |
553,898
-351,854
| -39% | -$12.9M | 0.06% | 380 |
|
|
2018
Q1 | $31M | Sell |
905,752
-52,103
| -5% | -$1.83M | 0.08% | 299 |
|
|
2017
Q4 | $31.4M | Buy |
957,855
+125,190
| +15% | +$4.31M | 0.08% | 296 |
|
|
2017
Q3 | $27.8M | Buy |
832,665
+88,920
| +12% | +$3.06M | 0.08% | 286 |
|
|
2017
Q2 | $26.4M | Buy |
743,745
+232,662
| +46% | +$7.86M | 0.09% | 275 |
|
|
2017
Q1 | $15.7M | Buy |
+511,083
| New | +$15.8M | 0.05% | 426 |
|
Other funds holding QGEN
Two Sigma Advisers's QGEN Position: Q2 2025 in Review
Two Sigma Advisers sold out of Qiagen (QGEN) in Q2 2025, closing a stake of 127,854 shares — an estimated $5.13M sold.
Two Sigma Advisers first reported a position in QGEN in Q1 2017 and held it in 30 quarters. The position peaked at $72.5M in Q3 2020. 317 funds tracked by Wall St. Rank hold QGEN as of Q2 2025.
- Two Sigma Advisers reported no remaining Qiagen position as of Q2 2025 after selling out during the quarter.
- Two Sigma Advisers sold 127,854 Qiagen shares in Q2 2025, an estimated $5.13M.
- Two Sigma Advisers first reported a position in Qiagen in Q1 2017 and held it in 30 quarters.
- Two Sigma Advisers's Qiagen position peaked at $72.5M in Q3 2020.
- 317 funds tracked by Wall St. Rank held Qiagen as of Q2 2025.
Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.